Intestinal bacteria are affected by antidiabetic drugs

December 2, 2015
pills

Intestinal bacteria change their composition and function when diabetic patients are treated with the drug metformin.

Most of the around 100 trillion bacteria living in hiding in our intestines - the gut microbiota - are difficult to grow using traditional methods, because they do not tolerate atmospheric oxygen. Within the past few years, new research based on gene technology and advanced bioinformatics has made it possible to analyse the composition and function of from their DNA. The bacteria produce many different types of substances that affect our physiology and health in numerous ways.

In the field of disease research, changes in the composition and function of the complex intestinal bacterial communities - so-called dysbioses - have become a focus area. It is, however, a weakness of the studies that researchers have not taken into account the potential effects of drugs on the patients' intestinal bacteria.

For that reason, it is not possible to determine which dysbiosis is associated with specific diseases and which changes in intestinal bacteria are associated with medical treatment. At the same time, conflicting results from research in intestinal bacteria are reported for the same disease. It might be due to the fact that the effect of drugs on the composition and function of the gut microbiota has not been taken into account.

Metformin makes intestinal bacteria produce fatty acids

European and Chinese researchers in the EU-funded MetaHIT consortium have studied the intestinal bacterial communities from Danish, Swedish and Chinese patients with type 2 diabetes as well as from healthy individuals; a total of 784 people were studied. The purpose of these studies were to separate changes in gut microbiota associated with disease from changes that may be associated with the intake of certain types of medication. The findings have recently been published in the prestigious international journal Nature.

The study shows that the most frequently used drug for the treatment of levels, metformin, causes favourable changes in the gut microbiota in patients with type 2 diabetes. This boosts the capability of the bacteria to produce certain types of short-chain fatty acids, such as butyric acid and propionic acid. These fatty acids can reduce in different ways. Metformin is, however, also known for having adverse effects on the gastrointestinal tract, for example bloating and increased flatulence. The study has provided the researchers with a possible explanation, since patients treated with metformin have more in their intestines, which may be one of the causes of the inconveniences.

"We weren't able to show that other types of antidiabetic drugs had any actual impact on the . When studying type 2 diabetes patients not being treated with , we did, however, discover that they - irrespective of whether they were from Denmark, China or Sweden - had fewer of the bacteria which produce the health-promoting short-chain . Whether the lack of certain combinations of fatty acid producing intestinal bacterial species is one of the factors contributing to type 2 diabetes is currently being investigated," says Professor Oluf Borbye Pedersen from the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, who is the senior author on the Nature report.

Explore further: Diet lacking soluble fiber promotes weight gain, mouse study suggests

More information: Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, DOI: 10.1038/nature15766

Related Stories

Diet lacking soluble fiber promotes weight gain, mouse study suggests

November 2, 2015
Eating too much high-fat, high-calorie food is considered the primary cause of obesity and obesity-related disease, including diabetes. While the excess calories consumed are a direct cause of the fat accumulation, scientists ...

Study reveals a key role your gut bacteria play in body's self-defense

October 19, 2015
Chalk up another reason why your gut bacteria are so critical to your health—and why these microorganisms could be the key to preventing a host of diseases. Scientists in Sweden have discovered that human intestinal flora ...

Gut microbiota affects intestinal integrity

August 13, 2014
Bacteria in the gut help the body to digest food, and stimulate the immune system. A PhD project at the National Food Institute, Technical University of Denmark, examines whether modulations of the gut bacterial composition ...

Novel intestinal bacterium provides human gut with healthy compounds

December 2, 2015
Fibers in our food are thought to be good for health since they are converted in the intestinal tract into the favourable compound butyrate, that is crucial to maintain intestinal health. In contrast, protein is believed ...

Gut bacteria could be blamed for obesity and diabetes

October 29, 2015
An excess of bacteria in the gut can change the way the liver processes fat and could lead to the development of metabolic syndrome, according to health researchers.

Dietary fat impacts autoimmune flare-ups in mice

October 20, 2015
Dietary fat may impact the severity and duration of autoimmune flare-ups, suggests a study published on October 20 in the journal Immunity. Adjusting the length of fatty acids consumed by mice altered the function of T helper ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.